Around £2billion was added to the value of GSK after the pharmaceuticals giant agreed a £1.7billion settlement over claims that its heartburn medicine Zantac caused cancer. Shares rose 3.2 per ...
GSK has struck a $2.2 billion agreement to settle the vast majority of U.S. lawsuits filed against it over claims its Zantac heartburn remedy causes cancer. The British drugmaker’s settlement ...
"The settlement of $2.2 billion is lower than market expectations of $3.5 billion, and the announcement came sooner than expected. The Zantac clouds are lifting, and GSK will likely resolve the ...
My most recent relationship has ended as it usually does - amicably. The thought of having to go back online and find someone new to date makes me ill. I just went onto POF to see who is on there.
"The settlement of $2.2 billion is lower than market expectations of $3.5 billion, and the announcement came sooner than expected. The Zantac clouds are lifting, and GSK will likely resolve the few ...
GSK to pay out $2.2bn in Zantac settlements GSK PLC will pay ... have been either negative or flat in each month dating back to October 2022. RICS also reported readings covering demand, sales, and ...
One exception in electronics and devices is Back Market, a global marketplace that since 2014 has given consumers access to high-quality, professionally refurbished electronics – everything from ...